Clinical Trial Update: Mix Vaccine for Metastatic Sarcoma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial update evaluating a mixed vaccine for metastatic sarcoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Mixed vaccine

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Metastatic Sarcoma, Reaction - Mixed Vaccine | Phase 1, Phase 2 | Status: COMPLETED